Davanat FDA Approval Status
FDA Approved: No
Brand name: Davanat
Company: Galectin Therapeutics Inc.
Treatment for: Targeted Drug Delivery
Davanat is a polysaccharide polymer comprised of mannnose and galactose in development for the targeted delivery of drugs used in the treatment of cancer.
Development timeline for Davanat
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.